Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-03-06 @ 4:51 PM
Study NCT ID:
NCT03811002
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-03
First Post:
2019-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2029-02-21
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-18
First Submit QC Date:
None
Study First Post Date:
2019-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-04-21
Results First Submit QC Date:
None
Results First Post Date:
2025-06-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED